3.2 Shared Decision-Making, Goal-Concordant Care & Decision Aids
Key Takeaways
- Shared Decision-Making (SDM) is an ethical and clinical imperative for preference-sensitive conditions where multiple medically reasonable alternatives exist with differing risk-benefit profiles.
- Glyn Elwyn's 3-Talk Model structures SDM into three sequential, iterative phases: Choice Talk (creating awareness of choice), Option Talk (comparing alternatives using risk literacy), and Decision Talk (integrating values to reach a decision).
- Certified Patient Decision Aids (PtDAs) complying with IPDAS standards systematically reduce decisional conflict, eliminate unrealistic expectations, and increase values-choice congruence.
- Goal-concordant care in serious illness requires structured elicitation frameworks—such as Ariadne Labs' Serious Illness Conversation Guide and VitalTalk—to align medical interventions with patient-defined values.
Shared Decision-Making, Goal-Concordant Care & Decision Aids
CPXP Exam Focus: The CPXP exam evaluates Shared Decision-Making (SDM) not merely as patient education, but as a formal deliberative partnership model. Key tested concepts include Elwyn's 3-Talk Model, the International Patient Decision Aid Standards (IPDAS), the distinction between preference-sensitive care vs. effective care, and structured serious illness conversational tools (VitalTalk SPIKES/REMAP and Ariadne Labs Serious Illness Conversation Guide).
Modern healthcare ethics has evolved from historical paternalism ("doctor knows best") through informative/consumerist care ("here is the menu of options, you decide") to Shared Decision-Making (SDM). In SDM, clinicians bring clinical evidence, diagnostic expertise, and probability estimates, while patients bring expertise in their own values, lifestyle preferences, risk tolerance, and life goals.
The Spectrum of Clinical Decisions
Not all clinical decisions require shared decision-making. CPXPs must distinguish between:
-
Effective Care (High Evidence / Clear Benefit):
- Interventions where clinical evidence overwhelmingly demonstrates benefit over harm (e.g., prescribing antibiotics for bacterial meningitis, emergent PCI for acute ST-elevation myocardial infarction).
- Communication Goal: Persuasive recommendation, informed consent, and adherence support.
-
Preference-Sensitive Care (Equipoise / Trade-Off Decisions):
- Scenarios where two or more medically reasonable options exist, or where the trade-off between benefits and harms depends entirely on personal values (e.g., lumpectomy with radiation vs. mastectomy for early breast cancer; surgical prostatectomy vs. active surveillance for low-risk prostate cancer; starting a biologic with immunosuppressive risks for rheumatoid arthritis).
- Communication Goal: Formal Shared Decision-Making (SDM).
Glyn Elwyn's 3-Talk Model of Shared Decision-Making
Developed by Professor Glyn Elwyn and colleagues, the 3-Talk Model provides a practical, step-by-step clinical roadmap for operationalizing shared decision-making during clinical encounters.
+--------------------------------------------------------------------------------+
| ELWYN'S 3-TALK MODEL OF SDM |
+--------------------------------------------------------------------------------+
| 1. CHOICE TALK: "Step back: A choice exists, and your opinion matters." |
| - Justify choice (equipoise, no single right answer) |
| - Check reaction & offer reassurance |
+--------------------------------------------------------------------------------+
| 2. OPTION TALK: "Compare: Here are the options, benefits, and trade-offs." |
| - Check existing knowledge & present balanced alternatives |
| - Use validated PtDAs & convey absolute risk numbers |
+--------------------------------------------------------------------------------+
| 3. DECISION TALK: "Deliberate: Given your values, what matters most to you?" |
| - Elicit preferences & guide trade-off deliberation |
| - Make, defer, or schedule decision review |
+--------------------------------------------------------------------------------+
Step 1: Choice Talk (Creating Awareness of Choice)
- Objective: Establish that a decision needs to be made, that multiple legitimate paths exist, and that the patient's preferences are essential to deciding.
- Core Actions:
- Summarize the situation: Acknowledge that the patient faces a health crossroad.
- State the choice explicitly: State clearly that there is more than one reasonable option.
- Offer partnership: Reassure the patient that you will support them throughout the decision process.
- Check reaction: Elicit immediate thoughts ("How does it feel to hear that you have a choice here?").
Step 2: Option Talk (Comparing Alternatives with Evidence)
- Objective: Provide clear, balanced information on the practical alternatives, including their distinct pros, cons, and uncertainties.
- Core Actions:
- Check prior knowledge: Ascertain what the patient already knows or has researched.
- List options clearly: Include the option of active surveillance or "doing nothing" when clinically appropriate.
- Describe trade-offs in plain language: Present benefits and side effects using natural frequencies (e.g., "5 out of 100 people" rather than relative percentages like "a 30% reduction").
- Deploy Patient Decision Aids (PtDAs): Introduce visual decision aids to facilitate cognitive processing.
- Check understanding: Use the teach-back method to verify that risks and trade-offs are grasped.
Step 3: Decision Talk (Deciding Based on Values)
- Objective: Elicit the patient's personal goals and guide them toward a decision that matches what matters most to them.
- Core Actions:
- Focus on values: Ask explicit value-elicitation questions ("When you think about the recovery time versus the risk of side effects, what worries you most?").
- Assess decision readiness: Gauge whether the patient is ready to decide or needs more time/family deliberation.
- Agree on a plan or next review: Formulate the agreed-upon clinical path or schedule a follow-up conversation.
Patient Decision Aids (PtDAs) & IPDAS Standards
Patient Decision Aids (PtDAs) are evidence-based tools (interactive web tools, booklets, video modules, grid sheets) designed to help patients make specific, deliberated choices among healthcare options. Unlike generic educational materials that describe disease pathophysiology, PtDAs explicitly present options, balance benefits vs. harms, and guide value clarification.
International Patient Decision Aid Standards (IPDAS) Collaboration
The IPDAS Collaboration establishes international quality criteria across three essential dimensions:
| IPDAS Quality Dimension | Core Standards & Requirements |
|---|---|
| 1. Content Quality | • Defines the decision and health condition explicitly.<br/>• Lists all viable options, including conservative management / watchful waiting.<br/>• Describes positive and negative outcomes with equal prominence.<br/>• Presents outcome probabilities using absolute risks, consistent denominators (e.g., per 1,000), and balanced visual pictographs (icon arrays).<br/>• Clarifies values through explicit trade-off exercises. |
| 2. Development Process | • Systematic literature search based on up-to-date synthesized clinical evidence.<br/>• Co-designed and field-tested with diverse patients and practicing clinicians.<br/>• Full disclosure of developer credentials, conflicts of interest, and funding sources.<br/>• Written at accessible literacy levels (5th to 6th grade reading level). |
| 3. Effectiveness Evaluation | • Validated in clinical trials showing significant increases in patient knowledge.<br/>• Proven reduction in decisional conflict (uncertainty, feeling uninformed, value mismatch).<br/>• Demonstrated improvement in values-congruent choices and reduction in post-treatment regret. |
Cochrane Review Evidence: Cochrane Systematic Reviews of over 105 randomized controlled trials confirm that patients exposed to validated PtDAs achieve higher knowledge scores, more accurate risk perceptions, reduced decisional conflict, lower rates of choosing major elective surgery (often choosing less invasive alternatives), and greater satisfaction without increasing anxiety.
Goal-Concordant Care & Serious Illness Conversations
In serious, life-limiting illnesses (advanced cancer, end-stage heart failure, neurodegenerative disease), clinical success is defined not by physiological metrics alone, but by goal-concordant care—ensuring that every diagnostic and therapeutic intervention strictly aligns with the patient's authentic values and definitions of quality of life.
Ariadne Labs Serious Illness Conversation Guide
Developed by Dr. Atul Gawande and Ariadne Labs, the Serious Illness Conversation Guide (SICG) provides clinicians with a structured, compassionate conversational framework:
1. Set Up: Introduce the conversation and seek permission to discuss the future.
2. Understand: Assess patient's current understanding of their illness and prognosis.
3. Share: Share prognosis as a range or time horizon with tailored information.
4. Explore: Elicit key goals, critical abilities, fears, and trade-offs.
5. Close: Summarize what was heard, make recommendations, and document in the EHR.
Core Value-Elicitation Questions from the SICG:
- "What are your most important goals or hopes if your health worsens?"
- "What are your biggest fears and worries about your illness and treatment?"
- "What abilities or activities are so crucial to your life that you cannot imagine living without them?"
- "If you become sicker, how much are you willing to go through for the possibility of gaining more time?"
- "How much do your family members know about your priorities and wishes?"
VitalTalk: SPIKES and REMAP Frameworks
-
SPIKES Protocol for Delivering Difficult News:
- Setting (Privacy, seating, tissues)
- Perception (Assess what the patient already knows)
- Invitation (Ask how much detail they want)
- Knowledge (Deliver clear news with a warning shot: "I have some serious results to share")
- Empathy (Respond to emotions using NURSE statements)
- Strategy and Summary (Outline next steps clearly)
-
REMAP Protocol for Goals of Care Re-framing:
- R — Reframe: "We are in a different place with your disease today."
- E — Expect Emotion: Validate distress with NURSE statements.
- M — Map the Future: "Given where things are, what is most important to you?"
- A — Align with Values: "As I listen to what matters most, it sounds like being home and comfortable is top priority."
- P — Propose a Plan: Recommend a clinical plan (e.g., palliative care/hospice) that matches their articulated values.
Advance Care Planning (ACP) & Healthcare Proxies
Advance Care Planning (ACP) is an iterative communication process wherein individuals identify their values, appoint trusted surrogate decision-makers, and document treatment preferences for future medical incapacity.
Legal & Clinical ACP Instruments
| Instrument | Legal Status | Clinical Function | Scope & Authority |
|---|---|---|---|
| Durable Power of Attorney for Healthcare (DPOA-HC) / Healthcare Proxy | Legal document | Designates a surrogate decision-maker (agent) to make healthcare decisions only when the patient loses decision-making capacity. | Highest legal authority for medical decisions when patient is incapacitated. Governed by substituted judgment. |
| Living Will | Legal document | Specifies hypothetical treatment preferences (e.g., mechanical ventilation, artificial nutrition/hydration) in scenarios of terminal illness or persistent vegetative state. | Informs surrogate and clinicians of preferences; often ambiguous in acute gray-zone clinical presentations. |
| POLST / MOLST (Physician/Medical Orders for Life-Sustaining Treatment) | Actionable medical order | Translates patient goals into immediate, standardized, portable physician orders (CPR vs. DNR; Intubation vs. Non-invasive ventilation; Comfort measures only vs. Full intervention). | Legally binding clinical orders recognized by EMS, emergency departments, and long-term care facilities across settings. |
Legal Standards for Surrogate Decision-Making
Surrogates must apply decision criteria in strict hierarchical order:
- Substituted Judgment Standard: The surrogate must make the decision that the patient would have made if they were currently capable of speaking for themselves, based on their known values, prior statements, and life history.
- Best Interests Standard: Used only when the patient's authentic wishes are completely unknown and cannot be deduced. The surrogate and clinical team decide what would produce the best overall outcome for the patient.
A 62-year-old patient with localized, low-risk prostate cancer meets with his urologist. The clinician begins the conversation by stating: 'There are two widely accepted approaches for your condition: active surveillance with regular monitoring, or radical surgery. Both have similar long-term survival rates, but very different side effects on daily living. Because neither is universally superior, your personal preferences and lifestyle priorities will guide our choice.' According to Elwyn's 3-Talk Model of Shared Decision-Making, which phase is the clinician executing?
Which of the following characteristics is a mandatory quality criterion for Patient Decision Aids (PtDAs) under the International Patient Decision Aid Standards (IPDAS)?
An appointed healthcare proxy is asked to make a treatment decision regarding mechanical ventilation for an incapacitated patient with end-stage COPD. The patient had previously stated to family on multiple occasions that she never wanted to be kept alive on breathing machines if she could not talk or recognize them. The proxy decides against intubation based on these statements. Which ethical standard of surrogate decision-making has the proxy exercised?